Economic evaluation in evidence-based practice

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 9, 2002, Pages 1239-1243

  Lens, Marko B ^a   Dawes, Martin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Economic evaluation; Guidelines

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATION; PRACTICE GUIDELINE;

EID: 0036723783     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.9.1239     Document Type: Article

References (34)

1. J. Economic evaluation: An introduction
2. Papers that tell you what things cost (economic analyses)
3. Clinical economics. A guide to the economic analysis of clinical practices
4. Methods for the economic evaluation of health care programmes
5. Health care CBA/CEA: An update on the growth and composition of the literature
6. Health care CBA and CEA from 1991 to 1996: An updated bibliography
7. Elementary economic evaluation in health care
8. Economic evaluation
9. Handling uncertainity in economic evaluations of healthcare interventions
10. Quality-adjusted life years, utility theory and healthy-years equivalence
11. Are health-related quality of life measures affected by the mode of administration?
12. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?
13. Quality of economic evaluations in health care
14. The quality of reporting in published cost-utility analyses, 1976-1997
15. Economic analysis alongside clinical trials. Revisiting the methodological issues
16. Quality of systematic reviews of economic evaluations in health care
17. Cost and cost-effectiveness guidelines: Which ones to use?
18. Guidelines for the pharmaceutical industry on preparation to the Pharmaceutical Benefits Advisory Committee: Including major submissions involving economic analyses
19. Ontario guidelines for economic analysis of pharmaceutical products
20. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative workshop for Pharmacoeconomics
21. Economic evaluation under managed competition: Evidence from the UK
22. NHS Economic Evaluation Database for healthcare decision makers
23. Can economic evaluation guidelines improve efficiency in resource allocation? The cases of Portugal
24. Are guidelines for peer-reviewing economic evaluations necessary? A survey of current editorial practice
25. How to read reviews and economic analyses
26. Cost-effectiveness in health and medicine
27. Guidelines for authors and peer reviewers of economic submissions to the British Medical Journal
28. Users' guides to the medical literature. XII. How to use articles about health-related quality of life
29. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid?
30. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients?
31. Design, analysis and presentation of multinational economic studies; the need for guidance
32. Evaluating the British Medical Journal guidelines for economic submissions: Prospective audit of economic submissions to British Medical Journal and The Lancet
33. The emerging government requirement for economic evaluation of pharmaceuticals
34. Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium